Search Results 191-200 of 32234 for Ovarian
A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer · Overview · Participation eligibility · Participating Mayo Clinic ...
Many women have ovarian cysts at some time. Most are harmless, but some can cause serious symptoms. Know what symptoms to watch for.
Dowdy studies the genetic changes in ovarian cancer that predict improved response to treatment and identifies new treatment options for both ovarian and ...
— Premenopausal women who have their ovaries surgically removed face an increased risk of developing chronic kidney disease, according to a Mayo Clinic study ...
BRCA1 carriers face an average cumulative risk of 67 percent for breast cancer and 45 percent for ovarian cancer by age 80. For BRCA2 carriers, those average ...
About this study. The purpose of this study is to determine if women with diminished ovarian reserve have shortened telomere lengths compared to women with ...
Ovarian/fallopian tube/peritoneal cancer; Endometrial/uterine cancer; Ovarian cysts and masses; Pelvic masses; Cervical cancer; Vulvar cancer; Vaginal cancer ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...
Cediranib maleate may stop the growth of ovarian, fallopian tube, or primary peritoneal cancer by blocking the growth of new blood vessels necessary for tumor ...
... Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression. Print ... ovarian epithelial carcinoma. CA125 response is defined as ≥ 50% decrease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!